The emerging therapy of this peptide represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – leading to https://tirzepatide-peptide586489.dsiblogger.com/75139094/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment